Suicidal ideation at psychiatric emergency presentation predicts trajectories of functional disability and symptom burden in mood and anxiety disorders: A prospective cohort study
Abstract
Suicidal ideation (SI) is common among patients presenting to psychiatric emergency departments (EDs), yet its association with longer-term clinical and functional outcomes remains insufficiently understood. This study examined trajectories of functional disability, depressive and anxiety symptoms, and alcohol misuse among patients with mood and anxiety disorders according to SI status at ED presentation. Data were drawn from a prospective cohort of 261 adults with mood and anxiety disorders presenting to a psychiatric ED and followed for 12 months. Linear mixed-effects models examined longitudinal outcomes according to baseline SI status, adjusting for sociodemographic, clinical, and psychosocial factors. A secondary analysis examined longitudinal associations between time-varying SI and depressive symptoms. Baseline SI was associated with greater functional disability and more severe depressive and anxiety symptoms throughout follow-up period, but not with alcohol misuse. Time-by-SI interactions were nonsignificant for all outcomes, indicating similar trajectories regardless of baseline SI. Depressive and anxiety symptoms improved over follow-up, whereas functional disability increased at discharge before stabilizing, and alcohol misuse decreased only at 12 months. Poor sleep satisfaction, chronic physical illness, and higher impulsivity were associated with poorer outcomes. Male sex and religious or spiritual coping were associated with lower functional disability and/or…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 261 participants or records.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.